{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-087548","form_type":"8-K/A","ticker":"TWST","cik":"0001581280","company_name":"Twist Bioscience Corp","filed_at":"2023-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.423812+00:00","generated_at":"2026-06-12T05:59:38.042351+00:00","sec_items":["2.05"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Twist Bioscience reports $12.7M restructuring costs, exceeding prior $9-11M estimate","bullets":["Cumulative pre-tax restructuring costs of $12.7M recognized through June 30, 2023.","Broke down as $8.6M severance, $3.6M asset impairments, and $0.4M other costs.","Expects additional severance up to $0.4M and other costs up to $0.6M.","Restructuring includes ~270 employee reduction (25% of workforce) and facility consolidation.","Previous estimate of $9-11M was based on initial plan approved May 3, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-087548","json":"https://secwatch.observer/filing/0001104659-23-087548.json","markdown":"https://secwatch.observer/filing/0001104659-23-087548.md","text":"https://secwatch.observer/filing/0001104659-23-087548.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1581280/000110465923087548/0001104659-23-087548-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1581280/000110465923087548/tm2322811d1_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T05:59:38.042351+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bd6c82bf4d16a498f091b3dbabb323f96b1ccb48","claim":"Twist Bioscience Corp announced a restructuring with charges of $9 and $11 million affecting South San Francisco and Wilsonville, Oregon facilities (approximately 270 employees worldwide, representing approximately 25% of the Company's total workforce).","evidence_excerpt":"Company expects it to be substantially completed by the end of fiscal year 2023. As disclosed in the Original Report, the Company expected to incur pre-tax charges of between $9 and $11 million, consisting of cash expenditures for employee severance and related benefit costs. The Company recognized cumulative pre-tax restructuring costs of approximately","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1581280/000110465923087548/0001104659-23-087548-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"$9 and $11 million"},{"label":"Affected area","value":"South San Francisco and Wilsonville, Oregon facilities"},{"label":"Headcount","value":"approximately 270 employees worldwide, representing approximately 25% of the Company's total workforce"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}